Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105254418 | 10525441 | 8 | F | 201303 | 20160830 | 20141017 | 20160907 | EXP | PHHY2014BR132561 | SANDOZ | 74.07 | YR | F | Y | 71.00000 | KG | 20160907 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105254418 | 10525441 | 1 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, EVERY 28 DAYS | U | 0 | 30 | MG | VIAL | /month | |||||
| 105254418 | 10525441 | 2 | SS | GALVUS | VILDAGLIPTIN | 1 | Unknown | 2 DF, QD | 0 | 2 | DF | TABLET | QD | ||||||
| 105254418 | 10525441 | 3 | SS | GALVUS | VILDAGLIPTIN | 1 | Unknown | 3 DF, QD | 0 | 3 | DF | TABLET | QD | ||||||
| 105254418 | 10525441 | 4 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 3 DF, QD | 75985 | 3 | DF | QD | |||||||
| 105254418 | 10525441 | 5 | SS | CABERGOLINA | CABERGOLINE | 1 | Unknown | 1 DF, QW | 0 | 1 | DF | TABLET | /wk | ||||||
| 105254418 | 10525441 | 6 | SS | CABERGOLINA | CABERGOLINE | 1 | Unknown | 2 DF, QW | X170A | 0 | 2 | DF | TABLET | /wk | |||||
| 105254418 | 10525441 | 7 | SS | CABERGOLINA | CABERGOLINE | 1 | Unknown | 6 DF, QW | 0 | 6 | DF | TABLET | /wk | ||||||
| 105254418 | 10525441 | 8 | SS | GLIMEPIRIDA | GLIMEPIRIDE | 1 | Unknown | 6 MG, QD | Y | 0 | 6 | MG | TABLET | QD | |||||
| 105254418 | 10525441 | 9 | C | AVASTIN | BEVACIZUMAB | 1 | Unknown | 1 DF, UNK | Y | 0 | 1 | DF | |||||||
| 105254418 | 10525441 | 10 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 50 MG, QD | 0 | 50 | MG | TABLET | QD | ||||||
| 105254418 | 10525441 | 11 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | TABLET | QD | ||||||
| 105254418 | 10525441 | 12 | C | MODURETIC 5-50 | AMILORIDE HYDROCHLORIDEHYDROCHLOROTHIAZIDE | 1 | Unknown | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 105254418 | 10525441 | 13 | C | MODURETIC 5-50 | AMILORIDE HYDROCHLORIDEHYDROCHLOROTHIAZIDE | 1 | 0 | TABLET | |||||||||||
| 105254418 | 10525441 | 14 | C | AMLODIPINA//AMLODIPINE | 2 | Unknown | 1 DF, Q12H | 0 | 1 | DF | TABLET | Q12H | |||||||
| 105254418 | 10525441 | 15 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | Unknown | 1 DF, FASTING PER DAY | 0 | 1 | DF | TABLET | |||||||
| 105254418 | 10525441 | 16 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 1 DF, AT BEDTIME | 0 | 1 | DF | TABLET | |||||||
| 105254418 | 10525441 | 17 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105254418 | 10525441 | 1 | Acromegaly |
| 105254418 | 10525441 | 2 | Diabetes mellitus |
| 105254418 | 10525441 | 4 | Product used for unknown indication |
| 105254418 | 10525441 | 5 | Acromegaly |
| 105254418 | 10525441 | 8 | Diabetes mellitus |
| 105254418 | 10525441 | 9 | Visual impairment |
| 105254418 | 10525441 | 10 | Hypertension |
| 105254418 | 10525441 | 12 | Hypertension |
| 105254418 | 10525441 | 13 | Diuretic therapy |
| 105254418 | 10525441 | 14 | Hypertension |
| 105254418 | 10525441 | 15 | Hormone replacement therapy |
| 105254418 | 10525441 | 16 | Insomnia |
| 105254418 | 10525441 | 17 | Stress |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105254418 | 10525441 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105254418 | 10525441 | Blood pressure decreased | |
| 105254418 | 10525441 | Body height decreased | |
| 105254418 | 10525441 | Bone disorder | |
| 105254418 | 10525441 | Decreased appetite | |
| 105254418 | 10525441 | Diabetes mellitus | |
| 105254418 | 10525441 | Dysuria | |
| 105254418 | 10525441 | Feeling hot | |
| 105254418 | 10525441 | Gait disturbance | |
| 105254418 | 10525441 | Headache | |
| 105254418 | 10525441 | Hypokinesia | |
| 105254418 | 10525441 | Injection site erythema | |
| 105254418 | 10525441 | Injection site nodule | |
| 105254418 | 10525441 | Injection site pain | |
| 105254418 | 10525441 | Limb discomfort | |
| 105254418 | 10525441 | Malaise | |
| 105254418 | 10525441 | Mass | |
| 105254418 | 10525441 | Nodule | |
| 105254418 | 10525441 | Pain | |
| 105254418 | 10525441 | Pain in extremity | |
| 105254418 | 10525441 | Thyroid disorder | |
| 105254418 | 10525441 | Venous occlusion | |
| 105254418 | 10525441 | Vision blurred | |
| 105254418 | 10525441 | Vitamin D decreased | |
| 105254418 | 10525441 | Weight decreased | |
| 105254418 | 10525441 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105254418 | 10525441 | 1 | 2010 | 0 | ||
| 105254418 | 10525441 | 2 | 201304 | 0 | ||
| 105254418 | 10525441 | 8 | 2013 | 0 | ||
| 105254418 | 10525441 | 9 | 20140216 | 20140216 | 0 |